CB1 – the new city quarter for Cambridge


27 July 2020

Deloitte Life Sciences Catalyst launches from CB1

Deloitte has launched the Life Sciences Catalyst in Cambridge, creating a collaborative platform to enable organisations in the biotech, medtech, pharmaceutical and technology sectors, as well as property investors, to come together to tackle the biggest challenge facing their industries.

Its location at One Station Square in CB1 – which welcomed business advisory firm Deloitte in 2017 – provides a physical presence in the city, as well as facilitating digital connections between people, businesses and investors through access to an online database of white papers, virtual events and access to Deloitte’s Biotech-in-a-Box suite of solutions – a ‘one stop shop’ to support the growth of small to mid-cap life sciences companies.

The Life Sciences Catalyst will be led by Deloitte partner and leader for the public sector technology and digital risk business, Fran Cousins. The programme aims to generate business growth by “supporting companies through their scale-up journey [by] providing dedicated support, investment summits, webinars, original insight, research and a network to catalyse success in the Cambridge economy,” says Cousins.

The UK’s Life Sciences sector continues to grow, particularly within the Ox-Cam Arc, with Savills identifying that the real estate industry will “respond to meet the continued growth in the life science sector”. The clusters of Oxford and Cambridge have attracted 62% of venture capital total investment since 2018 and continue to be an attractive offer for future development.

Deloitte’s Life Sciences Catalyst will be hosting an opening webinar on 22 September with a guest panel including John Haughey (Deloitte), Sir Mene Pangalos (AstraZeneca), Dr Andy Richards (Cancer Research UK) and Dr Susan Windham-Bannister (Biomedical Growth Strategies) as they explore the challenges facing the UK Life Sciences sector today. Further information to register and join can be found at www.deloitte.co.uk/lifesciencescatalyst


Keep up to date with the latest news and info from CB1 by following us on Twitter Twitter

see, be newsletter

In response to the impact of Covid-19, no hard copies of 'see, be' newsletters have been produced so far in 2020. In the meantime, please see our Twitter feed above for the latest news and articles.

You can download pdf versions of past issues below.